Loading...

VG Life Sciences Inc.

VGLSPNK
Healthcare
Biotechnology
$0.13
$0.12(124900.00%)
U.S. Market opens in 3h 59m

VG Life Sciences Inc. (VGLS) Stock Overview

Explore VG Life Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.6B
P/E Ratio-7424.31
EPS (TTM)N/A
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

VGLS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VG Life Sciences Inc. (VGLS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 99.92, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7424.31 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
124900.00%
5-Day Change
124900.004%
1-Month Change
124900.00%
3-Month Change
249900.00%
6-Month Change
249900.00%
Year-to-Date (YTD) Change
124900.004%
1-Year Change
124900.00%
3-Year Change
124900.00%
5-Year Change
1612.33%
All-Time (Max) Change
-99.89%

Contact Information

805 879 9000
121 Gray Avenue, Santa Barbara, CA, 93101

Company Facts

1 Employees
IPO DateDec 7, 1999
CountryUS
Actively Trading

Frequently Asked Questions